Analysts Set American Healthcare REIT, Inc. (NYSE:AHR) Target Price at $20.38

Shares of American Healthcare REIT, Inc. (NYSE:AHR) have been given an average recommendation of “Moderate Buy” by the eight analysts that are currently covering the stock, Marketbeat.com reports. One research analyst has rated the stock with a hold rating and seven have given a buy rating to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $23.00.

Several equities analysts recently issued reports on the company. Truist Financial upped their price objective on American Healthcare REIT from $22.00 to $27.00 and gave the company a “buy” rating in a research report on Friday, September 20th. Bank of America upped their price target on American Healthcare REIT from $27.00 to $31.00 and gave the company a “buy” rating in a report on Tuesday. KeyCorp increased their price objective on American Healthcare REIT from $16.00 to $27.00 and gave the company an “overweight” rating in a research report on Monday, September 16th. Morgan Stanley boosted their target price on American Healthcare REIT from $17.00 to $22.00 and gave the stock an “overweight” rating in a research report on Thursday, August 22nd. Finally, JMP Securities lifted their target price on shares of American Healthcare REIT from $18.00 to $30.00 and gave the stock a “market outperform” rating in a research report on Friday, September 20th.

American Healthcare REIT Price Performance

NYSE AHR opened at $26.20 on Friday. The stock’s fifty day moving average price is $19.82 and its 200-day moving average price is $16.26. The company has a debt-to-equity ratio of 0.60, a current ratio of 0.29 and a quick ratio of 0.29. American Healthcare REIT has a 12 month low of $12.63 and a 12 month high of $26.77.

American Healthcare REIT (NYSE:AHR) last released its quarterly earnings data on Monday, August 5th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.29 by ($0.28). The firm had revenue of $504.60 million for the quarter, compared to the consensus estimate of $506.55 million. American Healthcare REIT had a negative net margin of 1.99% and a negative return on equity of 2.20%. The business’s quarterly revenue was up 7.9% on a year-over-year basis. On average, sell-side analysts expect that American Healthcare REIT will post 1.28 earnings per share for the current year.

American Healthcare REIT Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 18th. Shareholders of record on Friday, September 20th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Friday, September 20th. This represents a $1.00 annualized dividend and a yield of 3.82%.

Institutional Trading of American Healthcare REIT

A number of institutional investors and hedge funds have recently bought and sold shares of AHR. Manning & Napier Advisors LLC purchased a new stake in shares of American Healthcare REIT during the 2nd quarter worth approximately $3,317,000. Quadrature Capital Ltd purchased a new position in American Healthcare REIT in the first quarter worth about $914,000. Centersquare Investment Management LLC bought a new stake in American Healthcare REIT during the first quarter worth approximately $63,269,000. Capstone Investment Advisors LLC bought a new stake in shares of American Healthcare REIT in the 1st quarter valued at approximately $1,201,000. Finally, Sei Investments Co. bought a new stake in shares of American Healthcare REIT in the 1st quarter valued at approximately $2,967,000. 16.68% of the stock is currently owned by institutional investors.

American Healthcare REIT Company Profile

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.